 NEW YORK, May 5, 2021 PRNewswire -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. fka Conversion Labs, Inc. LifeMD or the Company NASDAQ: LFMD and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-04004, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired LifeMD securities between January 19, 2021 and April 13, 2021, inclusive the Class Period. 